Asan Aorta and Peripheral Registry
PTA
Evaluation of Patients Underwent Revascularization of Aorta or Peripheral Artery at the Peripheral Vascular Disease Center, Asan Medical Center; A Single Center, Retrospective/Prospective Observational Study.
1 other identifier
observational
6,000
1 country
1
Brief Summary
The purpose of this study is to evaluate the clinical results of patients who received revascularization of the aorta and peripheral artery at Asan Medical Center.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 17, 2023
CompletedFirst Posted
Study publicly available on registry
September 5, 2023
CompletedStudy Start
First participant enrolled
September 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2034
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2044
July 17, 2024
July 1, 2024
11.3 years
August 17, 2023
July 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Rate of death from any cause
all-cause death
10years
Rate of major Adverse Limb Events
above-ankle amputation of the index limb,major index-limb reintervention including new bypass,interposition graft revision,thrombectomy, or thrombolysis
10years
Secondary Outcomes (8)
Rate of death from all cause including cardiovascular death
10years
Rate of stroke
10years
Rate of myocardial Infarction
10years
Rate of vascular complication
10years
Rate of bleeding
10years
- +3 more secondary outcomes
Interventions
Eligibility Criteria
Patients underwent Revascularization of Aorta or Peripheral artery from 2011 at the Peripheral Vascular Disease Center, Asan Medical Center
You may qualify if:
- Patients underwent Revascularization of Aorta or Peripheral artery from 2011 at the Peripheral Vascular Disease Center, Asan Medical Center
- Patients with aortic and peripheral artery disease are defined as:
- Thoacic aorta disease/ abdominal aorta disease
- Aneurysm
- Aortic dissection
- Penetrating aortic ulcer
- Peripheral artery occlusive disease
- Chronic Limb-Threatening Ischemia
- Claudication
- Acute limb ischemia
You may not qualify if:
- For prospective cohort, not agreeing to participate with written informed consent form
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Asan Medical Center
Seoul, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Seung-Whan Lee
Asan Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
August 17, 2023
First Posted
September 5, 2023
Study Start
September 20, 2023
Primary Completion (Estimated)
December 30, 2034
Study Completion (Estimated)
December 30, 2044
Last Updated
July 17, 2024
Record last verified: 2024-07